Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Micke

Showing results (61-70 of 165) with videos related to

Pageof 17
Sort By:
The Journal of Pathology|June 8, 2018
An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancerMasafumi Horie, Naoya Miyashita, Johanna Sofia Margareta Mattsson, et al.
Acta Oncologica (Stockholm, Sweden)|March 28, 2015
LRIG1 is a prognostic biomarker in non-small cell lung cancerSamuel Kvarnbrink, Terese Karlsson, Karolina Edlund, et al.
International Journal of Cancer|October 2, 2012
Landscape of somatic allelic imbalances and copy number alterations in human lung carcinomaJohan Staaf, Sofi Isaksson, Anna Karlsson, et al.
Archives of Toxicology|November 27, 2015
Identification of sample annotation errors in gene expression datasetsMiriam Lohr, Birte Hellwig, Karolina Edlund, et al.
The Journal of Investigative Dermatology|February 3, 2007
In situ identification of genes regulated specifically in fibroblasts of human basal cell carcinomaPatrick Micke, Kai Kappert, Mitsuhiro Ohshima, et al.
Lung Cancer (Amsterdam, Netherlands)|June 10, 2008
TA-MUC1 epitope in non-small cell lung cancerAndreas Kuemmel, Kristjan Single, Fernando Bittinger, et al.
Oncotarget|November 28, 2013
In situ mutation detection and visualization of intratumor heterogeneity for cancer research and diagnosticsIda Grundberg, Sara Kiflemariam, Marco Mignardi, et al.
Breast Cancer Research and Treatment|June 9, 2025
Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trialAxel Stenmark Tullberg, Viktoria Thurfjell, Anikó Kovács, et al.
Acta Oncologica (Stockholm, Sweden)|November 16, 2017
COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancerMiklos Gulyas, Johanna Sofia Margareta Mattsson, Andrea Lindgren, et al.
Cellular Oncology (Dordrecht, Netherlands)|March 3, 2025
Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancerHedvig Elfving, Hui Yu, Kaleab Kassete Fessehatsion, et al.
Pageof 17

Showing results (61-70 of 165) with videos related to

Sort By:
Pageof 17
The Journal of Pathology|June 8, 2018
An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancerMasafumi Horie, Naoya Miyashita, Johanna Sofia Margareta Mattsson, et al.
Acta Oncologica (Stockholm, Sweden)|March 28, 2015
LRIG1 is a prognostic biomarker in non-small cell lung cancerSamuel Kvarnbrink, Terese Karlsson, Karolina Edlund, et al.
International Journal of Cancer|October 2, 2012
Landscape of somatic allelic imbalances and copy number alterations in human lung carcinomaJohan Staaf, Sofi Isaksson, Anna Karlsson, et al.
Archives of Toxicology|November 27, 2015
Identification of sample annotation errors in gene expression datasetsMiriam Lohr, Birte Hellwig, Karolina Edlund, et al.
The Journal of Investigative Dermatology|February 3, 2007
In situ identification of genes regulated specifically in fibroblasts of human basal cell carcinomaPatrick Micke, Kai Kappert, Mitsuhiro Ohshima, et al.
Lung Cancer (Amsterdam, Netherlands)|June 10, 2008
TA-MUC1 epitope in non-small cell lung cancerAndreas Kuemmel, Kristjan Single, Fernando Bittinger, et al.
Oncotarget|November 28, 2013
In situ mutation detection and visualization of intratumor heterogeneity for cancer research and diagnosticsIda Grundberg, Sara Kiflemariam, Marco Mignardi, et al.
Breast Cancer Research and Treatment|June 9, 2025
Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trialAxel Stenmark Tullberg, Viktoria Thurfjell, Anikó Kovács, et al.
Acta Oncologica (Stockholm, Sweden)|November 16, 2017
COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancerMiklos Gulyas, Johanna Sofia Margareta Mattsson, Andrea Lindgren, et al.
Cellular Oncology (Dordrecht, Netherlands)|March 3, 2025
Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancerHedvig Elfving, Hui Yu, Kaleab Kassete Fessehatsion, et al.
Pageof 17